1.Standardization of management process for medical consumables in large-scale hospitals in western region
Chinese Medical Equipment Journal 1989;0(04):-
In order to scientifically and efficiently make use of the limited medical resources and gradually resolve the problem that "medical treatment is difficult and expensive",large-scale hospitals in the western region must reduce medical cost in purchasing,using and cost of medical consumables.This paper discusses the role of strengthening the management of medical consumables,and studies how to standardize the management process for medical consumables in large-scale hospitals in western region.
3.Current state of diagnosis and treatment of incomplete Kawasaki disease.
Chinese Journal of Pediatrics 2006;44(5):339-341
Child, Preschool
;
Coronary Aneurysm
;
diagnosis
;
etiology
;
prevention & control
;
Diagnosis, Differential
;
Early Diagnosis
;
Humans
;
Immunoglobulins, Intravenous
;
administration & dosage
;
therapeutic use
;
Immunologic Factors
;
administration & dosage
;
therapeutic use
;
Infant
;
Mucocutaneous Lymph Node Syndrome
;
classification
;
complications
;
diagnosis
;
drug therapy
;
Prognosis
5.Study on the correlation between the polymorphism of STATS gene and asthma
Juan DU ; Qingzhou FENG ; You ZUO ; Xuan LIU ; Huiling YE
Journal of Chinese Physician 2011;13(10):1316-1319
Objective To investigate the correlation rs2272087 polymorphism of STATS gene and asthma.Methods The polymerase chain reaction PCR- SBT technique was used to determine rs2272087 polymorphism in asthma and control group.Results The genotype of AA,AG and GG of rs2272087 were 0.600,0.412 and 0.167 in asthma group,and 0.430,0.200,0.367 in control group,respectively.The frequency of allele A and G was 0.903 and 0.344 in asthma group,and 0.656,0.970 in control group,respectively.There was significant difference in two groups(x2 =9.40,P <0.01 ;x2 =11.58,P <0.01 ).Conclusions The rs2272087 polymorphism of STAT5 gene may be an important candidate gene for asthma.
6.Effect of Metoprolol Treatment in Vasovagal Syncope in Children
pei-jun, JIAN ; jun-bao, DU ; qing-you, ZHANG
Journal of Applied Clinical Pediatrics 1992;0(05):-
Objective To explore the effect of the ?-blocker —metoprolol on the treatment of vasovagal syncope(VVS) in children.Methods Twenty-nine children with unexplained syncope and positive responses to head-up tilt test(HUT) were included in the study.Sixteen of them took metoprolol(treatment group) and 13 of them took vitamin B or oryzanol (control group) at least 2 weeks and HUT were repeated and syncope episodes were observed.Results In treatment group,9 of 16 patients had no syncope episode while 5 of 16 patients had fewer syncope episodes,1 case had more syncope episodes,and 1 case remained the same.HUT were repeated and 6 of 9 cases had negative outcome.In control group,1 of 13 patients had no syncope episode while 5 of 13 patients had fewer syncope episode,3 cases had more syncope episodes and 4 cases remained the same.HUT were repeated and 3 of 7 cases had ne-(gative) outcome.Conclusion These results indicate that adminstering metoprolol orally may be effective for VVS in children.
7.Three years follow-up report of two diffuse connective tissue disease cases caused by SARS-CoV-2 infection
WENG Shenghui ; SONG You ; LIU Xiaojing ; HU Hui ; DU Rong
China Tropical Medicine 2023;23(8):893-
Abstract: To report on two patients with Coronavirus Disease 2019 (COVID-19) combined with diffuse connective tissue disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection followed for nearly 3 years, in order to understand the long-term effects on the patients' immune system. Both patients were male, aged 81-82 years, and were hospitalized with fever on January 29, 2020 and February 10, 2020, respectively. Both were diagnosed with COVID-19 after positive SARS-CoV-2 polymerase chain reaction (PCR) tests. After receiving anti-infection treatment, cough suppressants, ex‐pectorants, and symptomatic supportive treatment, their body temperature returned to normal and two consecutive PCR tests were negative for SARS-CoV-2, and they were discharged from hospital. However, due to recurring fevers and varying degrees of rheumatic disease-related symptoms, both patients were readmitted to the hospital, indicating the presence of positive auto‐ antibodies and organ involvement. One patient recovered from COVID-19 with recurrent fever, joint pain, muscle aches and subcutaneous nodules, and was subsequently diagnosed with undifferentiated connective tissue disease. The other patient developed recurrent fever, mouth ulcers and rash after recovery from COVID-19 and was subsequently diagnosed with anti neutro phil cytoplasm antibody (ANCA)-associated vasculitis (AAV). The patient was treated with glucocorticoids and immunosuppres sive drugs and the symptoms resolved rapidly and subsequent laboratory and imaging examinations showed stable condition. However, due to self-termination of medication, their symptoms quickly relapsed, and further treatment with glucocorticoids and immunosuppressive agents resulted in sustained stability of their condition. The erythrocyte sedimentation rate and hyper‐sensitive C-reactive protein remained within normal limits, and lung CT scans showed stable lesions with partial absorption.SARS-CoV-2 infection may have long-term effects on patients' immune systems, leading to abnormal immune responses and diffuse connective tissue disease. This suggests that regular follow-up observation of immune system-related diseases may be necessary for elderly patients with COVID-19.
9.Effect of hypertensive agent on regional cerebral blood flow in patients with hypertensive intracerebral hemorrhage
You ZUO ; Juan DU ; Jianliang CHEN ; Qingsuo ZHAO ; Shaowei ZHANG
Chinese Journal of Emergency Medicine 2008;17(7):742-744
Objective To investigate effects of hypertensive agents on regional cerebral blood flow (rCBF)and prognosis in patients with hypertensive intracerebral hemorrhage (HICH). Method Thirty patients withFILCH were divided into group A,B and C according to mean arterial pressure(MAP) with various ranges of <10%, 10 ~ 20%, and > 20%, respectively. Patients of three groups were checked with single photon emissioncomputed tomography (SPECT),and computerized tomography of head successively, 24 hours, 3 ~ 5 days, and 12~ 15 days after admission for the assessment of therapeutic effects. The rtes of the decrease in rCBF compared be-twecn groups were analyzed with t test. Neurologic function defect scale, activities of living scale and number of re-bleeding compared between two groups were analyzed by X2 test, respectively. Results There were statisticallysignificant differences in the rate of the decrease in rCBF. The neurologic function defect scale and activities of liv-ing scale at 24 hours, 3 ~ 5 days, and 12 ~ 15 days after admission compared between group C and group A, andbetween group C and group B showed significant differences ( P < 0.05). There were statistically significant differ-enees in rebleeding during acute phase of HICH between group A and group B or group C (P < 0.05).Conclusions If the systolic blood pressure is above 185mmHg or diastolic blood pressure over 95mmHg,it is ra-tional and safe to lower the MAP by about 15% with hypotensive gents so as to minimize the impact on regionalcerebral blood flow.